Ascendis Pharma (ASND1N) Q4 2025 Earnings Report
MX:ASND1N Q4 2025 EPS Results
- Actual EPS
- -MXN 11.43
- Consensus EPS
- -MXN 1.66
- Beat/Miss
- Missed by -MXN 9.76
- One Year Ago EPS
- -MXN 13.29
MX:ASND1N Q4 2025 Revenue Results
- Actual Revenue
- MXN 5.35B
- Expected Revenue
- MXN 5.10B
- Beat/Miss
- Beat by +MXN 251.07M
- YoY Revenue Growth
- +55.28%
Earnings Announcement Details
- Quarter
- Q4 2025
- Date
- 02/11/2026
- Time
- After Close
- Conference Call
- Wednesday, February 11, 2026
MX:ASND1N Upcoming Earnings
Ascendis Pharma's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q4 2025 Earnings Call Audio
MX:ASND1N Q4 2025 Earnings Call
0:00 / 0:00
Q4 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ASND1N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | 16.39- | -20.77 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | 31.1058.79 | -17.03 | 445.12% (+75.82) | |
| May 07, 2026 | 2026 (Q1) | 3.37202.53 | -32.82 | 717.09% (+235.36) | |
| Feb 11, 2026 | 2025 (Q4) | -1.66-11.43 | -13.29 | 14.06% (+1.87) | |
| Nov 12, 2025 | 2025 (Q3) | -5.07-20.77 | -35.73 | 41.86% (+14.96) | |
| Aug 07, 2025 | 2025 (Q2) | -26.71-17.03 | -39.68 | 57.07% (+22.64) | |
| May 01, 2025 | 2025 (Q1) | -30.47-32.82 | -47.78 | 31.30% (+14.96) | |
| Feb 12, 2025 | 2024 (Q4) | -20.44-13.29 | -31.99 | 58.44% (+18.70) | |
| Nov 14, 2024 | 2024 (Q3) | -32.51-35.73 | -55.88 | 36.06% (+20.15) | |
| Sep 03, 2024 | 2024 (Q2) | -30.29-39.68 | -44.87 | 11.57% (+5.19) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
